Thousands of men with advanced prostate cancer in England are set to benefit from a life-extending drug that can be taken at home after it was given the go-ahead for NHS use. The recommendation from Nice comes days after new analysis found that prostate cancer is now the most common cancer in the UK. Prostate Cancer UK found that 64,425 men were diagnosed with the disease in 2022, compared with 61,640 people with breast cancer, which had previously been the most common cancer. Prostate cancer officially became the most common cancer in England a year ago, but new figures from Scotland, with data from Wales and Northern Ireland, enabled the UK-wide figure. Amy Rylance, assistant director of health improvement at Prostate Cancer UK, said: 'When hormone therapy stops working for a man with advanced prostate cancer, who is unable to have chemotherapy, it can be hugely distressing.

Source: Daily Mail January 24, 2026 01:48 UTC